By vgreene, 10 July, 2019 HER2 status testing on metastatic site by validated IHC assay or by validated dual-probe ISH assay1
By vgreene, 10 July, 2019 Consider cytogenetic analyses to identify the following genetic abnormalities:
By vgreene, 10 July, 2019 chromosomal translocations: t(8;21)(q22;q22.1), t(16;16)(p13.1;q22), t(9;11)(p21.3;q23.2), t(6;9)(p23;q34.1), t(v;11q23.3), t(9;22), (q34.1;q11.2), t(3;3)(q21.3;q26.2)